• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.

作者信息

Fargnoli M C, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori M L, Motolese A, Betto P, Patruno C, Pigatto P, Peccianti C, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavo S P, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Stingeni L, Caruso C, Argenziano G

机构信息

Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Unit of Dermatology, Fondazione IRCCS Ca' Grande Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

J Dermatolog Treat. 2022 Mar;33(2):1146-1149. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 3.

DOI:10.1080/09546634.2020.1773379
PMID:32436765
Abstract
摘要

相似文献

1
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.度普利尤单抗治疗成人中重度特应性皮炎多中心真实世界经验的48周更新情况
J Dermatolog Treat. 2022 Mar;33(2):1146-1149. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 3.
2
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.一项关于度普利尤单抗治疗中度至重度特应性皮炎青少年有效性和安全性的意大利多中心真实世界经验的52周更新。
J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e384-e388. doi: 10.1111/jdv.18648. Epub 2022 Oct 18.
3
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.成人中重度特应性皮炎患者使用度普利尤单抗的有效性和安全性的真实世界经验。
J Dermatolog Treat. 2021 Aug;32(5):507-513. doi: 10.1080/09546634.2019.1682503. Epub 2019 Oct 28.
4
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.度普利尤单抗治疗青少年中重度特应性皮炎的临床意义：一项随机临床试验的事后分析。
Am J Clin Dermatol. 2020 Feb;21(1):119-131. doi: 10.1007/s40257-019-00478-y.
5
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.度普利尤单抗可改善中重度特应性皮炎患者的报告症状、焦虑和抑郁症状以及健康相关生活质量：来自随机试验 SOLO 1 和 SOLO 2 的汇总数据分析。
J Dermatolog Treat. 2020 Sep;31(6):606-614. doi: 10.1080/09546634.2019.1612836. Epub 2019 Jun 9.
6
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.度普利尤单抗与环孢素治疗成人中重度特应性皮炎：基于湿疹面积及严重程度指数的间接比较
Acta Derm Venereol. 2019 Sep 1;99(10):851-857. doi: 10.2340/00015555-3219.
7
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.度普利尤单抗治疗成人特应性皮炎钱币状湿疹表型的有效性。
Dermatol Ther. 2020 May;33(3):e13290. doi: 10.1111/dth.13290. Epub 2020 Mar 11.
8
Severe eczema in Wiskott-Aldrich syndrome-related disorder successfully treated with dupilumab.威斯科特-奥尔德里奇综合征相关疾病导致的严重湿疹经度普利尤单抗治疗后得到成功缓解。
Pediatr Dermatol. 2024 Jan-Feb;41(1):143-144. doi: 10.1111/pde.15397. Epub 2023 Jul 19.
9
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.接受度普利尤单抗治疗的中度至重度特应性皮炎患者中与度普利尤单抗相关的嗜酸性粒细胞增多症。
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e394-e396. doi: 10.1111/jdv.17177. Epub 2021 Mar 5.
10
The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.度普利尤单抗治疗中重度特应性皮炎患者慢性手部湿疹的长期疗效：荷兰 BioDay 登记研究 52 周结果。
Contact Dermatitis. 2022 Aug;87(2):185-191. doi: 10.1111/cod.14104. Epub 2022 Apr 24.

引用本文的文献

1
Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review.度普利尤单抗在成人和青少年特应性皮炎患者中的药物生存、留存及持续性：一项叙述性文献综述
Adv Ther. 2025 Jan;42(1):94-105. doi: 10.1007/s12325-024-03052-z. Epub 2024 Nov 15.
2
A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities.一项关于度普利尤单抗治疗特应性皮炎患者的真实世界研究，其中包括患有恶性肿瘤和其他内科合并症的患者。
JAAD Int. 2024 Jan 17;15:5-11. doi: 10.1016/j.jdin.2024.01.002. eCollection 2024 Jun.
3
Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience.
度普利尤单抗在哥伦比亚中重度特应性皮炎成人患者中的有效性和安全性：真实世界经验
World Allergy Organ J. 2023 Apr 5;16(4):100763. doi: 10.1016/j.waojou.2023.100763. eCollection 2023 Apr.
4
Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer.度普利尤单抗治疗晚期癌症患者的重度特应性皮炎
J Clin Med. 2023 Feb 2;12(3):1191. doi: 10.3390/jcm12031191.
5
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.度普利尤单抗在特应性皮炎患者中的真实世界有效性：电子病历数据集分析
Dermatol Ther (Heidelb). 2022 Jun;12(6):1337-1350. doi: 10.1007/s13555-022-00731-z. Epub 2022 May 11.
6
Ocular Adverse Effects in Atopic Dermatitis Patients Treated With Dupilumab: A Bibliometric Analysis.使用度普利尤单抗治疗的特应性皮炎患者的眼部不良反应：一项文献计量分析
Front Med (Lausanne). 2022 Mar 3;9:802036. doi: 10.3389/fmed.2022.802036. eCollection 2022.
7
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.度普利尤单抗治疗特应性皮炎的真实世界有效性和安全性文献综述。
JID Innov. 2021 Jul 30;1(3):100042. doi: 10.1016/j.xjidi.2021.100042. eCollection 2021 Sep.
8
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management.特应性皮炎患者皮肤科治疗专家建议：从过去展望新冠疫情下的疫苗接种管理。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3268-3275. doi: 10.1080/21645515.2021.1925502. Epub 2021 Jun 25.
9
Experimental Drugs with the Potential to Treat Atopic Eczema.具有治疗特应性皮炎潜力的实验性药物。
J Exp Pharmacol. 2021 May 12;13:487-498. doi: 10.2147/JEP.S259299. eCollection 2021.